Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
0.4278
-0.0291 (-6.37%)
At close: Mar 28, 2025, 4:00 PM
0.4301
+0.0023 (0.54%)
Pre-market: Mar 31, 2025, 8:22 AM EDT

Generation Bio Co. Statistics

Total Valuation

GBIO has a market cap or net worth of $28.67 million. The enterprise value is -$63.00 million.

Market Cap 28.67M
Enterprise Value -63.00M

Important Dates

The last earnings date was Thursday, March 13, 2025, after market close.

Earnings Date Mar 13, 2025
Ex-Dividend Date n/a

Share Statistics

GBIO has 67.01 million shares outstanding. The number of shares has increased by 3.32% in one year.

Current Share Class 67.01M
Shares Outstanding 67.01M
Shares Change (YoY) +3.32%
Shares Change (QoQ) +0.08%
Owned by Insiders (%) 6.10%
Owned by Institutions (%) 69.09%
Float 48.78M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.43
Forward PS 5.06
PB Ratio 0.33
P/TBV Ratio 0.33
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.50, with a Debt / Equity ratio of 1.09.

Current Ratio 5.50
Quick Ratio 5.33
Debt / Equity 1.09
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -91.02% and return on invested capital (ROIC) is -20.59%.

Return on Equity (ROE) -91.02%
Return on Assets (ROA) -16.34%
Return on Invested Capital (ROIC) -20.59%
Return on Capital Employed (ROCE) -40.38%
Revenue Per Employee $172,974
Profits Per Employee -$1.14M
Employee Count 115
Asset Turnover 0.07
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -88.44% in the last 52 weeks. The beta is 2.72, so GBIO's price volatility has been higher than the market average.

Beta (5Y) 2.72
52-Week Price Change -88.44%
50-Day Moving Average 0.66
200-Day Moving Average 1.81
Relative Strength Index (RSI) 29.11
Average Volume (20 Days) 451,568

Short Selling Information

The latest short interest is 1.68 million, so 2.51% of the outstanding shares have been sold short.

Short Interest 1.68M
Short Previous Month 2.56M
Short % of Shares Out 2.51%
Short % of Float 3.44%
Short Ratio (days to cover) 4.00

Income Statement

In the last 12 months, GBIO had revenue of $19.89 million and -$131.67 million in losses. Loss per share was -$1.98.

Revenue 19.89M
Gross Profit -27.88M
Operating Income -79.19M
Pretax Income -158.43M
Net Income -131.67M
EBITDA -74.26M
EBIT -79.19M
Loss Per Share -$1.98
Full Income Statement

Balance Sheet

The company has $185.22 million in cash and $93.56 million in debt, giving a net cash position of $91.66 million or $1.37 per share.

Cash & Cash Equivalents 185.22M
Total Debt 93.56M
Net Cash 91.66M
Net Cash Per Share $1.37
Equity (Book Value) 86.20M
Book Value Per Share 1.29
Working Capital 157.85M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$88.56 million and capital expenditures -$2.40 million, giving a free cash flow of -$90.96 million.

Operating Cash Flow -88.56M
Capital Expenditures -2.40M
Free Cash Flow -90.96M
FCF Per Share -$1.36
Full Cash Flow Statement

Margins

Gross Margin -140.16%
Operating Margin -398.11%
Pretax Margin -661.91%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

GBIO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.32%
Shareholder Yield n/a
Earnings Yield -459.32%
FCF Yield -317.32%

Analyst Forecast

The average price target for GBIO is $7.33, which is 1,613.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target $7.33
Price Target Difference 1,613.42%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 3.53%
EPS Growth Forecast (5Y) -18.66%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

GBIO has an Altman Z-Score of -3.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -3.79
Piotroski F-Score 3